Alliin
CAS No. 556-27-4
Alliin( (S)-3-(Allylsulphinyl)-L-alanine )
Catalog No. M20467 CAS No. 556-27-4
Alliin is a garlic organosulfur compound that possesses various pharmacological properties.alliin protected against LPS-induced ALI by activating PPARγ which subsequently inhibited LPS-induced NF-κB activation and inflammatory response.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 86 | In Stock |
|
| 10MG | 149 | In Stock |
|
| 25MG | 287 | In Stock |
|
| 50MG | 431 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlliin
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlliin is a garlic organosulfur compound that possesses various pharmacological properties.alliin protected against LPS-induced ALI by activating PPARγ which subsequently inhibited LPS-induced NF-κB activation and inflammatory response.
-
DescriptionAlliin is a garlic organosulfur compound that possesses various pharmacological properties.alliin protected against LPS-induced ALI by activating PPARγ which subsequently inhibited LPS-induced NF-κB activation and inflammatory response. Alliin might be used as an anti-inflammatory agent in the treatment of ALI.
-
In VitroCell Viability Assay Cell Line:HepG2 cells Concentration:10-1280 μM Incubation Time:24 h Result:Decreased the cell viability at concentrations from 320 μM to 1280 μM.Did not have cell toxicity at concentrations from 0 μM to 160 μM.Western Blot Analysis Cell Line:HepG2 cells Concentration:0-160 μM Incubation Time:23 hResult:Increased the expression of p-AMPK and decreased the protein expression of AMPK at concentrations of 80 μM and 160 μM.Inhibited the protein expression of SREBP-1, FAS, SREBP-2 and HMGCR by 1,3-DCP-induced at concentrations of 80 μM and 160 μM.Western Blot Analysis Cell Line:RAW264.7Concentration:100 μg/mL Incubation Time:6 h Result:Inhibited the protein expression ofiNOS, IL-1β, IL-6, and TNF-α, and the production of NO.Suppressed the expression of iNOS, TNF-α, IL-1β, and IL-6 mRNAs.Blocked JNK/ERK1/2-mediated transcriptional activation of PPARγ.
-
In VivoAnimal Model:DSS colitis mouse model Dosage:500 mg/kg Administration:i.g., 10 days Result:Decrease hematochezia symptom and diarrhea symptom.Improved weight loss.Reduced colon injury and inflammatory cell infiltration, restored the structure of colon epithelial and crypt.Reduced the expression of iNOS, TNF-α and IL-6 mRNAs.
-
Synonyms(S)-3-(Allylsulphinyl)-L-alanine
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARγ|NF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number556-27-4
-
Formula Weight177.22
-
Molecular FormulaC6H11NO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:3 mg/mL (16.92 mM)
-
SMILESN[C@@H](CS(=O)CC=C)C(O)=O
-
Chemical Name((S)-allylsulfinyl)-D-alanine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Y L Guo X Y He W et al. Effects of alliin on LPS-induced acute lung injury by activating PPARγ[J]. Microbial Pathogenesis 2017 110:375-379.
molnova catalog
related products
-
Clofibrate
Clofibrate (Atromid-S), a fibric acid derivative used in the treatment of hyperlipoproteinemia type III and severe hypertriglyceridemia.
-
Sulotroban
sulotroban is a TXA2 receptor antagonist that acts synergistically with iloprost to inhibit TXA2-dependent platelet activation.
-
Inolitazone
Inolitazone an agonist of PPARγ(IC50 = 0.8 nM) with high-affinity.
Cart
sales@molnova.com